Consistent with these findings, we found that the expression of SPI1 was significantly negatively correlated with that of AML1-ETO in the BM samples from patients with t(8;21) AML (n = 26, Fig. 1J). This evidence concerns the gene SPI1 and acute myeloid leukemia.